10-Q: TerrAscend Q3: Michigan Exit Drives Loss Amid Revenue Dip

TerrAscend Corp. reported a significantly increased net loss in Q3 2025, primarily due to substantial impairment charges from its Michigan market exit, despite stable revenue from continuing operations.

Summary

• Net loss for the three months ended September 30, 2025, increased to $24,554,000 from $21,419,000 in the prior year, largely due to discontinued Michigan operations.
• Net loss for the nine months ended September 30, 2025, increased to $84,929,000 from $42,508,000 in the prior year.
• Revenue from continuing operations remained relatively flat at $65,101,000 for Q3 2025, a slight decrease of $60,000 from Q3 2024.
• Nine-month revenue from continuing operations decreased by 4% to $194,410,000, down from $201,632,000 in 2024.
• Gross profit margin improved to 52.1% in Q3 2025 (from 51.0% in Q3 2024) and to 52.4% for the nine months (from 50.0% in 9M 2024).
• General and administrative expenses decreased by 14% in Q3 2025 to $21,327,000, mainly due to reduced share-based compensation.
• Loss from discontinued Michigan operations, net of tax, surged to $14,647,000 in Q3 2025 and $60,952,000 for the nine months, including impairment charges of $6,312,000 and $41,271,000 respectively.
• Adjusted EBITDA from continuing operations remained relatively flat at $16,998,000 for Q3 2025 and $51,160,000 for the nine months.
• Free Cash Flow from continuing operations for the nine months decreased to $18,701,000 from $35,313,000 in the prior year, driven by increased working capital and higher income taxes paid.
• Total loans payable increased to $230,048,000 as of September 30, 2025, from $204,545,000 at December 31, 2024.
• Working capital decreased significantly to $43,058,000 as of September 30, 2025, from $85,839,000 at December 31, 2024.
• Shareholders' equity decreased to $95,481,000 as of September 30, 2025, from $176,816,000 at December 31, 2024.

Sentiment

Score: 4

Explanation: The significant increase in net loss and substantial impairment charges from discontinued operations, coupled with a notable decrease in working capital and shareholder equity, indicate a negative overall financial performance despite some operational efficiencies in continuing segments. The strategic exit from Michigan is a long-term positive, but its immediate financial impact is severe.

Positives

• Gross profit margin from continuing operations improved to 52.1% in Q3 2025 and 52.4% for the nine months, indicating better efficiency.
• General and administrative expenses decreased by 14% in Q3 2025, reflecting reduced share-based compensation and prior-year one-time charges.
• Net loss from continuing operations improved to $(9,907,000) in Q3 2025 from $(15,836,000) in Q3 2024.
• The company completed the acquisition of certain assets of Ratio Cannabis, LLC in Ohio, expanding its operational footprint.
• A gain of $1,171,000 from revaluation of contingent consideration in Q3 2025, compared to a loss of $327,000 in Q3 2024, due to common share issuance reducing future liability likelihood.

Negatives

• Overall net loss significantly increased to $24,554,000 in Q3 2025 and $84,929,000 for the nine months, primarily due to discontinued Michigan operations.
• Loss from discontinued Michigan operations, net of tax, dramatically increased to $14,647,000 in Q3 2025 and $60,952,000 for the nine months.
• Significant impairment charges of $6,312,000 in Q3 2025 and $41,271,000 for the nine months were recognized related to the Michigan exit.
• Wholesale revenue declined by $1,527,000 in Q3 2025 and $7,066,000 for the nine months, attributed to increased competition and price compression.
• Free Cash Flow from continuing operations decreased to $18,701,000 for the nine months ended September 30, 2025, from $35,313,000 in the prior year.
• Working capital decreased substantially to $43,058,000 from $85,839,000 at year-end 2024.
• Total shareholders' equity decreased to $95,481,000 from $176,816,000 at year-end 2024.
• Total loans payable increased to $230,048,000 as of September 30, 2025, from $204,545,000 at year-end 2024.

Risks

• The use of cannabis remains illegal under U.S. federal law, posing a significant risk to U.S. operations.
• Increased competition and continued price compression in the wholesale cannabis market negatively impact revenue.
• The Michigan market exit resulted in substantial impairment charges and losses due to an expedited sales strategy, incomplete constructions, and market saturation.
• Uncertainty around the timing of legislative changes may result in unfavorable tax treatment, particularly concerning Section 280E of the Code.
• The company believes it is reasonably possible that unrecognized tax benefits will increase over the next twelve months due to its 280E Tax Position.
• Fluctuations in the company's stock price can lead to losses on the fair value of derivative liabilities, as seen in Q3 2025.
• The company's ability to generate cash flows from operations and obtain necessary financing on acceptable terms is crucial for future requirements.
• The company is subject to financial covenants on its loans payable, and failure to maintain compliance could trigger an event of default.

Future Outlook

The company expects to fund future capital requirements through cash from ongoing operations, market offerings, additional debt, sale of real property, sale-leaseback transactions, and exercise of options and warrants. The Michigan market exit is expected to be substantially completed by the end of 2025. The company anticipates G&A expenses to increase in absolute dollars as the business grows. The company believes it is reasonably possible that unrecognized tax benefits will increase over the next twelve months due to its 280E Tax Position.

Management Comments

• Management believes the interim condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and include all normal recurring adjustments necessary for fair presentation.
• Management determined that the plan to exit the Michigan market is a strategic shift that will have a major effect on operations and financial results.
• Management believes that any ultimate liability from legal proceedings would not have a material adverse effect on the Consolidated Balance Sheets or Consolidated Statements of Operations and Comprehensive Loss.

Industry Context

The company's wholesale revenue continues to be impacted by increased competition and price compression, reflecting broader industry trends in the cannabis market. The strategic exit from Michigan is a response to market saturation and intense competition in that specific state. The acquisition in Ohio indicates a focus on expanding into new, potentially less saturated, or higher-growth state markets within the U.S. cannabis industry.

Comparison to Industry Standards

• The filing does not provide specific global benchmarks or detailed comparisons to specific comparable companies, projects, or results within the cannabis industry.
• The company notes that increased competition and price compression in the wholesale market are factors impacting its revenue, which is a common trend observed across various U.S. cannabis markets.
• The decision to exit the Michigan market was influenced by 'continued increase of competition' and 'market saturation and price compression' in that state, suggesting that market conditions there fell below internal or industry-expected performance standards for profitability.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in a number of lawsuits incidental to its business, including litigation related to intellectual property, product liability, employment, and commercial matters.
• Management believes that any ultimate liability from these matters would not have a material adverse effect on the Consolidated Balance Sheets or Consolidated Statements of Operations and Comprehensive Loss.
• As of September 30, 2025, there were no pending lawsuits that could reasonably be expected to have a material effect on the company's Consolidated Financial Statements.

Related Party Transactions

• Certain funds controlled by Jason Wild, the company's Executive Chairman, held $7,100,000 of the total principal balance of the FG Loan as of September 30, 2025.
• Funds controlled by Jason Wild invested approximately $1,600,000 under the FG Loan Amendment on July 8, 2025.

Stakeholder Impact

• Shareholders: Experienced a significant decrease in total shareholders' equity and an increased net loss, potentially impacting share value. The new share repurchase program could offer some support.
• Employees: The Michigan exit involves $1,050,000 to $1,200,000 in cash expenditures for employee transition, notice period, and severance payments, indicating job losses in that market. Amended employment agreements for CEO and Chief People and Legal Officer provide enhanced compensation and severance terms.
• Creditors: The company upsized its FG Loan, increasing total debt, but also used proceeds to retire other indebtedness, consolidating debt under new terms. Compliance with debt covenants is ongoing.
• Customers: The exit from Michigan will impact customers in that state, while the acquisition in Ohio and planned acquisition in New Jersey aim to expand customer reach in new markets.

Next Steps

• Substantially complete the sale of assets of the Michigan business by the end of 2025.
• Integrate the acquired Ratio Cannabis, LLC operations in Ohio.
• Complete the acquisition of Union Chill Cannabis Company LLC in New Jersey, subject to customary closing conditions and regulatory approvals.
• Continue to manage and potentially increase general and administrative expenses as the business grows.
• Address potential increases in unrecognized tax benefits related to the 280E Tax Position.

Key Dates

Recommendation

While TerrAscend's continuing operations show some positive trends like improved gross margins and reduced G&A expenses, the substantial losses and impairment charges from the Michigan market exit, coupled with a significant decline in working capital and shareholder equity, present considerable headwinds. The strategic shift away from Michigan is a long-term positive, but its immediate financial impact is severe. The increase in debt, even for growth initiatives, adds to the risk profile. Investors should hold to observe the successful completion of the Michigan exit, the integration of new acquisitions, and the company's ability to return to overall profitability and positive free cash flow from continuing operations before considering further investment. The stock option repricing and share repurchase program are positive signals from management, but the overall financial picture is currently challenged.

Keywords

Cannabis, Marijuana, SEC Filing, 10-Q, Quarterly Report, Financial Results, TerrAscend, Discontinued Operations, Michigan Market, Impairment Charges, Wholesale Revenue, Retail Revenue, Adjusted EBITDA, Debt Financing, Capital Raise, Share Repurchase, Ohio Acquisition, Cannabis Regulation, Risk Factors, Corporate Governance